Adenosine-based cell therapy approaches for pharmacoresistant epilepsies.
about
Adenosine-associated delivery systemsAdenosine augmentation ameliorates psychotic and cognitive endophenotypes of schizophrenia.Quantitative analysis of adenosine using liquid chromatography/atmospheric pressure chemical ionization-tandem mass spectrometry (LC/APCI-MS/MS)A novel mouse model for sudden unexpected death in epilepsy (SUDEP): role of impaired adenosine clearance.Comonitoring of adenosine and dopamine using the Wireless Instantaneous Neurotransmitter Concentration System: proof of principleSilk fibroin encapsulated powder reservoirs for sustained release of adenosineGene therapy in epilepsy.Adenosine, ketogenic diet and epilepsy: the emerging therapeutic relationship between metabolism and brain activityUncoupling of astrogliosis from epileptogenesis in adenosine kinase (ADK) transgenic mice.Are purines mediators of the anticonvulsant/neuroprotective effects of ketogenic diets?Modulators of nucleoside metabolism in the therapy of brain diseases.Lentiviral RNAi-induced downregulation of adenosine kinase in human mesenchymal stem cell grafts: a novel perspective for seizure control.The adenosine kinase hypothesis of epileptogenesisSilk polymer-based adenosine release: therapeutic potential for epilepsy.Adenosine dysfunction in astrogliosis: cause for seizure generation?Adenosine as a neuromodulator in neurological diseases.The promise of gene therapy for the treatment of epilepsy.Antiepileptic effects of silk-polymer based adenosine release in kindled rats.Engineered adenosine-releasing cells for epilepsy therapy: human mesenchymal stem cells and human embryonic stem cellsTransplantation of GABA-producing cells for seizure control in models of temporal lobe epilepsyA Molecular Approach to Epilepsy Management: from Current Therapeutic Methods to Preconditioning Efforts.Neurabin scaffolding of adenosine receptor and RGS4 regulates anti-seizure effect of endogenous adenosine.Adenosine kinase is a target for the prediction and prevention of epileptogenesis in mice.Human mesenchymal stem cell grafts engineered to release adenosine reduce chronic seizures in a mouse model of CA3-selective epileptogenesis.Epilepsy and astrocyte energy metabolism.Ozone protective effects against PTZ-induced generalized seizures are mediated by reestablishment of cellular redox balance and A1 adenosine receptors.Genome Editing in Neuroepithelial Stem Cells to Generate Human Neurons with High Adenosine-Releasing Capacity.
P2860
Q26785351-BC3475B1-7599-45C6-B48A-A9A8C9DD75DDQ30466024-A6B3A2C2-512A-4DAE-B51F-C64E1B223740Q33446142-2628FC8A-93B0-45A9-B320-3FDAB3CCF651Q33751068-4C21DBEC-4BAD-4E1E-979B-3D828095FECEQ33782226-F0F8E074-7DD3-4CD6-95F1-E4DCA464D32DQ33846966-F7E991CB-F0BF-4801-921D-9FE5AFB59497Q33960096-9CDB3ECA-3764-4800-8BDE-C903BEE40EFFQ34101256-1CB4D9AF-08EB-4127-AFB8-9A6E8E851360Q34606639-88EB32E9-EF33-44AE-8FCC-61B624426446Q34777954-6D2A0AA3-1118-44F7-B318-5620E4774AD3Q34842250-D5E31677-06A2-45B9-B9E4-3AAA4F76F4F9Q36391066-50D52148-55B9-4667-BB9E-4A40657B4038Q36515651-6ABA0013-9336-4C37-A362-B889B15BC07BQ36819103-B5B3FBAB-8D21-417C-B579-2B2FF54C9801Q36923994-329AC895-EA57-4271-A19D-36E6EEBB2EAFQ36974004-63698F0C-C446-474A-808A-151281A55DA1Q37021317-2760E2F5-F321-47F5-BA56-4E95A7D863D8Q37310106-A4DEADCD-B423-4953-AEE5-47351EF01057Q37426965-73945F96-09C7-4144-A28A-B1B814AAA567Q37426967-716B3C9B-AEAE-42E6-BCB5-E56A5BEE01EBQ38246632-6C833A4D-506E-4E32-ABD2-FCA7313537DBQ41775962-1D8AB0F7-FBB8-4E7D-AA33-DBB0B2B358F2Q41862804-FD6B2A76-4BAB-484C-8C4E-D22018F985C9Q42558822-F5013B96-75DF-49CA-8C1B-27AC30052CA3Q48051352-570873B3-2BBA-4858-AEE4-84868D8D922EQ48512998-EC5ECA4B-1DD0-4D62-9498-A2AE0203CFCAQ54981587-DD8259F2-BCC2-4CEA-8339-EA1FAB8388A8
P2860
Adenosine-based cell therapy approaches for pharmacoresistant epilepsies.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Adenosine-based cell therapy approaches for pharmacoresistant epilepsies.
@ast
Adenosine-based cell therapy approaches for pharmacoresistant epilepsies.
@en
type
label
Adenosine-based cell therapy approaches for pharmacoresistant epilepsies.
@ast
Adenosine-based cell therapy approaches for pharmacoresistant epilepsies.
@en
prefLabel
Adenosine-based cell therapy approaches for pharmacoresistant epilepsies.
@ast
Adenosine-based cell therapy approaches for pharmacoresistant epilepsies.
@en
P2860
P356
P1476
Adenosine-based cell therapy approaches for pharmacoresistant epilepsies
@en
P2093
Detlev Boison
P2860
P356
10.1159/000100356
P577
2007-01-01T00:00:00Z